SynthesisJournal of clinical psychology in medical settings2012
Cognitive-behavioral and pharmacological interventions for premenstrual syndrome or premenstrual dysphoric disorder: a meta-analysis.
Synthesis in Journal of clinical psychology in medical settings, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01961479 (Development and Evaluation of an Internet-based Cognitive Behaviour Therapy for Women With Premenstrual Syndrome), which is not on this map. Cited by 32 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Development and Evaluation of an Internet-based Cognitive Behaviour Therapy for Women With Premenstrual Syndrome (PMS)
Who cites it
32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 90 citations in OpenAlex.
- Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder.The Cochrane database of systematic reviews · 2024Pooled it
- Academic and Social Impact of Menstrual Disturbances in Female Medical Students: A Systematic Review and Meta-Analysis.Frontiers in medicine · 2022Pooled it
- Selective serotonin reuptake inhibitors for premenstrual syndrome.The Cochrane database of systematic reviews · 2013Pooled it
- Emotion-focused therapy for women with premenstrual dysphoric disorder: a randomized clinical controlled trial.BMC psychiatry · 2024Trial
- Trial
- Cardiovascular response to short-term fasting in menstrual phases in young women: an observational study.BMC women's health · 2015Trial
- Trial
- Premenstrual Disorders in Adolescents: An Interdisciplinary Perspective.Journal of clinical medicine · 2026Review
- Self-Guided Mental Health Interventions for Premenstrual Mood Symptoms.Current psychiatry reports · 2025Review
- Premenstrual dysphoric disorder in online peer support communities: a Reddit case study.Scientific reports · 2025Article
- The role of trait anger, rumination, and locus of control in the relationship between trauma, stress, and premenstrual disorders.Scientific reports · 2025Article
- Efficacy of open-label placebos for premenstrual syndrome: a randomised controlled trial.BMJ evidence-based medicine · 2025Article
- Article
- Probing corporeal awareness in women through virtual reality induction of embreathment illusion.Scientific reports · 2024Article
- Premenstrual syndrome: new insights into etiology and review of treatment methods.Frontiers in psychiatry · 2024Review
- Identification of emotion schemes in women with premenstrual dysphoric disorder (PMDD) using an emotion-focused therapy (EFT) approach: A qualitative study.Journal of education and health promotion · 2024Article
- Effects of cognitive emotion regulation strategies on mood and cortisol in daily life in women with premenstrual dysphoric disorder.Psychological medicine · 2023Article
- Diagnostic validity of premenstrual dysphoric disorder: revisited.Frontiers in global women's health · 2023Review
- Article
- Management of Premenstrual Dysphoric Disorder: A Scoping Review.International journal of women's health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current meta-analysis investigates the efficacy of psychotherapeutic interventions and psychopharmacotherapy for premenstrual syndrome (PMS) and premenstrual dysphoric disorder. Based on a multiple-phase literature search, controlled trials were selected according to a priori defined inclusion criteria. Data were extracted on the basis of a standardized coding scheme. The standardized weighted mean difference (random effects model) was used as effect size index. Dependent on outcome, 22 included studies obtained small to medium effect sizes for cognitive-behavioral interventions (range: d(+) = 0.24-0.70) and for serotonergic antidepressants (range: d(+) = 0.29-0.58), at post-assessment. Follow-ups were performed only in studies of cognitive-behavioral interventions (range: d(+) = 0.46-0.74). There was no evidence of a publication bias. For both cognitive-behavioral interventions and serotonergic antidepressants, efficacy in treatment of PMS was found to not be satisfactory. Future research should possibly focus more on a combination of both approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.